Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Pruritus, Notalgia Paresthetica
In brief
This is a 2-part, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin for moderate-to-severe pruritus in adult subjects with NP.
Key facts
- Study ID
- NCT05978063
- Run by
- Cara Therapeutics, Inc.
- People needed
- 214
- Starts
- 2023-08-01
- Expected to finish
- 2024-05-07
- Last updated by the study team
- 2024-06-21
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cara Therapeutics Study Site — Phoenix, Arizona, United States
- Cara Therapeutics Study Site — Fayetteville, Arkansas, United States
- Cara Therapeutics Study Site — Hot Springs, Arkansas, United States
- Cara Therapeutics Study Site — Encino, California, United States
- Cara Therapeutics Study Site — Fountain Valley, California, United States
- Cara Therapeutics Study Site — Los Angeles, California, United States
- Cara Therapeutics Study Site — Northridge, California, United States
- Cara Therapeutics Study Site — Valencia, California, United States
- Cara Therapeutics Study Site — Coral Gables, Florida, United States
- Cara Therapeutics Study Site — Hollywood, Florida, United States
- Cara Therapeutics Study Site — Lutz, Florida, United States
- Cara Therapeutics Study Site — Margate, Florida, United States
- Cara Therapeutics Study Site — Tampa, Florida, United States
- Cara Therapeutics Study Site — Indianapolis, Indiana, United States
- Cara Therapeutics Study Site — Plainfield, Indiana, United States
- Cara Therapeutics Study Site — West Lafayette, Indiana, United States
- Cara Therapeutics Study Site — Baton Rouge, Louisiana, United States
- Cara Therapeutics Study Site — Baton Rouge, Louisiana, United States
- Cara Therapeutics Study Site — Metairie, Louisiana, United States
- Cara Therapeutics Study Site — New Orleans, Louisiana, United States
- Cara Therapeutics Study Site — Rockville, Maryland, United States
- Cara Therapeutics Study Site — Fort Gratiot, Michigan, United States
- Cara Therapeutics Study Site — Reno, Nevada, United States
- Cara Therapeutics Study Site — Portsmouth, New Hampshire, United States
- Cara Therapeutics Study Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.